Understanding Dementia (Alzheimer's & Vascular & Frontotemporal & Lewy Body Dementia)

Overview

Dementia is an umbrella term for progressive disorders that damage brain cells and impair thinking enough to interfere with everyday functioning. Cognitive decline may affect memory, executive skills, language, attention, or visuospatial abilities. The video focuses on Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, and frontotemporal dementia.

Typical Progression

Symptoms vary, but the video describes a general course in stages:

• Pre-dementia: Subtle changes may appear years before dementia. These can include loss of smell, mild forgetfulness, or occasional difficulty finding words, without yet disrupting daily life.
• Early stage: Problems become noticeable to others and interfere with tasks such as taking medication, finding belongings, doing household tasks, managing money, and planning.
• Middle stage: People may struggle to learn new information and need help with personal care and hygiene. Disorientation and reduced awareness of their difficulties may develop, along with repetitive behavior, restlessness, or aggression.
• Late stage: A person may believe they are living in an earlier period of life, lose much of their ability to speak, and experience more anxiety, depression, hallucinations, or agitation. They may no longer recognize familiar people or places or notice dangers. Walking, swallowing, and eating can become difficult. Reduced mobility raises the risk of blood clots, while swallowing problems can lead to aspiration and pneumonia.

The video says each stage may last roughly two years after daily functioning becomes impaired, though the timeline varies.

Main Dementia Subtypes

Alzheimer’s Disease

• The most common subtype, estimated in the video at about 70% of cases.
• Associated with accumulations of:
  • Beta-amyloid plaques outside neurons.
  • Hyperphosphorylated tau tangles inside neurons.
• Beta-amyloid can form when amyloid precursor protein is processed first by beta-secretase and then by gamma-secretase.
• The abnormal proteins are associated with neuron dysfunction and death. The video highlights the hippocampus and parietal and temporal lobes.
• Common features include short-term memory loss, difficulty finding words, visuospatial problems such as getting lost, and limited awareness of memory problems.

Vascular Dementia

• Estimated at about 15% of cases.
• Results from impaired blood supply to the brain and resulting cell damage. It may follow a series of small, individually subtle strokes (“multi-infarct” dementia) or small-vessel disease.
• Progression may be stepwise: little change between events, followed by a sudden decline after another vascular injury.
• Early difficulties often involve planning, organization, and judgment.
• Risk factors mentioned include smoking, diabetes, atrial fibrillation, abnormal blood lipids, hypertension, and age.

Dementia with Lewy Bodies

• Estimated at about 10% of cases.
• Lewy bodies are deposits in neurons; the video identifies alpha-synuclein and ubiquitin as components. Lewy bodies are also associated with Parkinson’s disease dementia.
• Core features include fluctuating cognition, visual hallucinations, and parkinsonian symptoms such as slowed movement and rigidity. Falls and autonomic problems—such as low blood pressure on standing, incontinence, and constipation—may also occur.
• REM sleep disturbance and sensitivity to antipsychotic medication are described as suggestive features.
• The video’s diagnostic summary is:
  • Probable: At least one core feature plus at least one suggestive feature.
  • Possible: One or more suggestive features alone.

Frontotemporal Dementia

• A major cause of dementia in people under 65; the video gives a mean onset age of 53.
• The video discusses disease processes involving TDP-43 and tau.
• Behavioral variant: Often the most common subtype. Early personality and behavior changes can include disinhibition and social withdrawal. Tau-containing “Pick bodies” are mentioned.
• Semantic variant: Language problems, including difficulty finding words and understanding meaning; described as a fluent form of aphasia.
• Non-fluent primary progressive aphasia: Labored, hesitant speech.
• The semantic and non-fluent variants are grouped under primary progressive aphasia.

Risk Factors

• Age: The video identifies increasing age as the largest general risk factor and cites prevalence rising from about 2% at age 65 to as high as 40% at age 85.
• Family history and genetics: Having a first-degree relative with Alzheimer’s is said to increase risk by 10–30%. The video describes some familial Alzheimer’s as autosomal dominant, especially in early-onset cases.
• Early-onset Alzheimer’s: Defined as dementia before age 65 and estimated at around 5% of cases. Down syndrome is highlighted as a risk factor because an extra copy of chromosome 21 may increase amyloid precursor protein and beta-amyloid production.
• Genes: For early-onset Alzheimer’s, the video names the amyloid precursor protein gene and presenilin 1 and 2. For later-onset disease, it discusses APOE, especially the E4 variant.
• Other factors: Dementia is more common in women, possibly because women tend to live longer. Lower cognitive reserve—associated in the video with social isolation, less education, or lower job complexity—is also discussed. Vascular risk factors are relevant to vascular dementia.

Diagnosis

• The video says the only conclusive confirmation of Alzheimer’s is brain biopsy with histological examination, which is rarely performed in living patients. PET imaging is being developed to detect relevant changes non-invasively.
• In practice, suspicion is generally based on clinical history and cognitive assessment, often with a largely normal neurological examination.
• Assessment may include a mental state examination, such as the Mini-Mental State Examination or Montreal Cognitive Assessment.
• Blood tests are used to look for reversible or alternative causes of cognitive impairment, including vitamin B12 or folate deficiency, hypothyroidism, electrolyte abnormalities, and infections such as Lyme disease or neurosyphilis.
• CT imaging can help rule out other causes and may show brain atrophy, but atrophy alone is not specific to dementia.
• Genetic testing is not routine and is generally reserved for rare familial cases.

Treatment and Support

• The video states that there is currently no cure.
• Cholinesterase inhibitors, including donepezil, galantamine, and rivastigmine, reduce the breakdown of acetylcholine, a neurotransmitter involved in cognition and memory.
• Memantine, an NMDA-receptor antagonist, is another medication discussed. These drug classes may slow cognitive decline, but the video says their effect on overall survival is inconclusive.
• For vascular dementia, management includes addressing identified risk factors, which may help slow progression.
• Non-drug approaches include keeping the environment familiar, monitoring comfort, and redirecting attention.
• Anxiety, depression, and psychosis should also be recognized and treated.
• Regular aerobic exercise is described as potentially slowing Alzheimer’s progression.
• The video notes that pneumonia is a common cause of death, partly because swallowing difficulties can lead to aspiration.

Speakers and Sources Featured

• Speaker: An unnamed narrator for Rhesus Medicine.
• Other speakers or cited sources: None are identified in the subtitles. The video refers generally to “experts” but does not name them.